{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:19:08Z","timestamp":1767651548173},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,2,29]],"date-time":"2008-02-29T00:00:00Z","timestamp":1204243200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1007\/s10495-008-0188-7","type":"journal-article","created":{"date-parts":[[2008,2,29]],"date-time":"2008-02-29T08:11:58Z","timestamp":1204272718000},"page":"553-561","source":"Crossref","is-referenced-by-count":6,"title":["Human osteoclasts differentiated from umbilical cord blood precursors are less prone to apoptotic stimuli than osteoclasts from peripheral blood"],"prefix":"10.1007","volume":"13","author":[{"given":"Letizia","family":"Penolazzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Pocaterra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Tavanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Lambertini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fortunato","family":"Vesce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Gambari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Piva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,2,29]]},"reference":[{"key":"188_CR1","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1593","volume":"13","author":"M Zaidi","year":"2007","unstructured":"Zaidi M (2007) Skeletal remodeling in health and disease. Nat Med 13:791\u2013801","journal-title":"Nat Med"},{"key":"188_CR2","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1159\/000106484","volume":"27","author":"S Tanaka","year":"2007","unstructured":"Tanaka S (2007) Signaling axis in osteoclast biology and therapeutic targeting in the RANKL\/RANK\/OPG system. Am J Nephrol 27:466\u2013478","journal-title":"Am J Nephrol"},{"key":"188_CR3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1172\/JCI116179","volume":"91","author":"SN Tanaka","year":"1993","unstructured":"Tanaka SN, Takahashi, Udagawa N et\u00a0al (1993) Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J Clin Invest 91:257\u2013263","journal-title":"J Clin Invest"},{"key":"188_CR4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337\u2013342","journal-title":"Nature"},{"key":"188_CR5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molmed.2005.11.007","volume":"12","author":"T Wada","year":"2006","unstructured":"Wada T, Nakashima T, Hiroshi N, Penninger JM (2006) RANKL\u2013RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med 12:17\u201325","journal-title":"Trends Mol Med"},{"key":"188_CR6","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1210\/endo.139.10.6331","volume":"139","author":"JM Quinn","year":"1998","unstructured":"Quinn JM, Elliott J, Gillespie MT, Martin TJ (1998) A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in\u00a0vitro. Endocrinology 139:4424\u20134427","journal-title":"Endocrinology"},{"key":"188_CR7","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1359\/jbmr.060604","volume":"21","author":"GJ Atkins","year":"2006","unstructured":"Atkins GJ, Kostakis P, Vincent C et\u00a0al (2006) RANK Expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone. J Bone Miner Res 21:1339\u20131349","journal-title":"J Bone Miner Res"},{"key":"188_CR8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1365-2141.2000.01986.x","volume":"109","author":"A Erices","year":"2000","unstructured":"Erices A, Conget P, Minguell JJ (2000) Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 109:235\u2013242","journal-title":"Br J Haematol"},{"key":"188_CR9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bbrc.2007.03.072","volume":"357","author":"B Sun","year":"2007","unstructured":"Sun B, Jeong YH, Jung JW, Seo K, Lee YS, Kang KS (2007) Regulation of human umbilical cord blood-derived multi-potent stem cells by autogenic osteoclast-based niche-like structure. Biochem Biophys Res Commun 357:92\u201398","journal-title":"Biochem Biophys Res Commun"},{"key":"188_CR10","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1172\/JCI11459","volume":"106","author":"MJ Mann","year":"2000","unstructured":"Mann MJ, Dzau VJ (2000) Therapeutic applications of transcription factor decoy oligonucleotides. J Clin Invest 106:1071\u20131075","journal-title":"J Clin Invest"},{"key":"188_CR11","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1124\/mol.106.024273","volume":"70","author":"H Gao","year":"2006","unstructured":"Gao H, Xiao J, Sun Q et\u00a0al (2006) A single decoy oligodeoxynucleotides targeting multiple oncoproteins produces strong anticancer effects. Mol Pharmacol 70:1621\u20131629","journal-title":"Mol Pharmacol"},{"key":"188_CR12","first-page":"145","volume":"14","author":"L Penolazzi","year":"2004","unstructured":"Penolazzi L, Borgatti M, Lambertini E et\u00a0al (2004) Peptide nucleic acid-DNA decoy chimeras targeting NF-kappaB transcription factors: induction of apoptosis in human primary osteoclasts. Int J Mol Med 14:145\u2013152","journal-title":"Int J Mol Med"},{"key":"188_CR13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jcb.20410","volume":"95","author":"CJ Day","year":"2005","unstructured":"Day CJ, Kim MS, Lopez CM, Nicholson GC, Morrison NA (2005) NFAT expression in human osteoclasts. J Cell Biochem 95:17\u201323","journal-title":"J Cell Biochem"},{"key":"188_CR14","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2007.07.025","volume":"130","author":"T Nakamura","year":"2007","unstructured":"Nakamura T, Imai Y, Matsumoto T et\u00a0al (2007) Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 130:811\u2013823","journal-title":"Cell"},{"key":"188_CR15","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s10495-005-0618-8","volume":"10","author":"R Piva","year":"2005","unstructured":"Piva R, Penolazzi L, Lambertini E, Giordano S, Gambari R (2005) Induction of apoptosis of human primary osteoclasts treated with a transcription factor decoy mimicking a promoter region of estrogen receptor alpha. Apoptosis 10:1079\u20131094","journal-title":"Apoptosis"},{"key":"188_CR16","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1210\/endo.140.2.6573","volume":"140","author":"K Matsuzaki","year":"1999","unstructured":"Matsuzaki K, Katayama K, Takahashi Y et\u00a0al (1999) Human osteoclast-like cells are formed from peripheral blood mononuclear cells in a coculture with SaOS-2 cells transfected with the parathyroid hormone (PTH)\/PTH-related protein receptor gene. Endocrinology 140:925\u2013932","journal-title":"Endocrinology"},{"key":"188_CR17","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1196\/annals.1378.092","volume":"1091","author":"R Piva","year":"2006","unstructured":"Piva R, Penolazzi L, Zennaro M et\u00a0al (2006) Induction of apoptosis of osteoclasts by targeting transcription factors with decoy molecules. Ann NY Acad Sci 1091:509\u2013516","journal-title":"Ann NY Acad Sci"},{"key":"188_CR18","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1124\/mol.107.034561","volume":"71","author":"L Penolazzi","year":"2007","unstructured":"Penolazzi L, Zennaro M, Lambertini E et\u00a0al (2007) Induction of estrogen receptor alpha expression with decoy oligonucleotide targeted to NFATc1 binding sites in osteoblasts. Mol Pharmacol 71:1457\u20131462","journal-title":"Mol Pharmacol"},{"key":"188_CR19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2474-7-21","volume":"7","author":"CE Evans","year":"2006","unstructured":"Evans CE, Mylchreest S, Andrew JG (2006) Age of donor alters the effect of cyclic hydrostatic pressure on production by human macrophages and osteoblasts of sRANKL, OPG and RANK. BMC Musculoskelet Disord 7:21","journal-title":"BMC Musculoskelet Disord"},{"key":"188_CR20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bone.2006.09.023","volume":"40","author":"M Asagiri","year":"2007","unstructured":"Asagiri M, Takayanagi H (2007) The molecular understanding of osteoclast differentiation. Bone 40:251\u2013264","journal-title":"Bone"},{"key":"188_CR21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11154-006-9009-x","volume":"7","author":"A Bruzzaniti","year":"2006","unstructured":"Bruzzaniti A, Baron R (2006) Molecular regulation of osteoclast activity. Rev Endocr Metab Disord 7:123\u2013139","journal-title":"Rev Endocr Metab Disord"},{"key":"188_CR22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.biochem.69.1.217","volume":"69","author":"A Strasser","year":"2000","unstructured":"Strasser A, O\u2019Connor L, Dixit VM (2000) Apoptosis signaling. Annu Rev Biochem 69:217\u2013245","journal-title":"Annu Rev Biochem"},{"key":"188_CR23","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.1093\/emboj\/cdg635","volume":"22","author":"T Akiyama","year":"2003","unstructured":"Akiyama T, Bouillet P, Miyazaki T et\u00a0al (2003) Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim. EMBO J 22:6653\u20136664","journal-title":"EMBO J"},{"key":"188_CR24","doi-asserted-by":"crossref","first-page":"17800","DOI":"10.1074\/jbc.M008270200","volume":"276","author":"L Sevilla","year":"2001","unstructured":"Sevilla L, Zaldumbide A, Carlotti F, Dayem MA, Pognonec P, Boulukos KE (2001) Bcl-XL expression correlates with primary macrophage differentiation, activation of functional competence, and survival and results from synergistic transcriptional activation by Ets2 and PU.1. J Biol Chem 276:17800\u201317807","journal-title":"J Biol Chem"},{"key":"188_CR25","first-page":"5315","volume":"58","author":"I Tamm","year":"1998","unstructured":"Tamm I, Wang Y, Sausville E et\u00a0al (1998) IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 58:5315\u20135320","journal-title":"Cancer Res"},{"key":"188_CR26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/jcb.10503","volume":"89","author":"A Gingery","year":"2003","unstructured":"Gingery A, Bradley E, Shaw A, Oursler MJ (2003) Phosphatidylinositol 3-kinase coordinately activates the MEK\/ERK and AKT\/NFkappaB pathways to maintain osteoclast survival. J Cell Biochem 89:165\u2013179","journal-title":"J Cell Biochem"},{"key":"188_CR27","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/jcb.21311","volume":"101","author":"PH Stern","year":"2007","unstructured":"Stern PH (2007) Antiresorptive agents and osteoclast apoptosis. J Cell Bioch 101:1087\u20131096","journal-title":"J Cell Bioch"},{"key":"188_CR28","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/335440a0","volume":"335","author":"DL Vaux","year":"1988","unstructured":"Vaux DL, Cory S, Adams JM (1988) Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440\u2013442","journal-title":"Nature"},{"key":"188_CR29","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/path.1463","volume":"201","author":"CP Brandwood","year":"2003","unstructured":"Brandwood CP, Hoyland JA, Hillarby MC et\u00a0al (2003) Apoptotic gene expression in Paget\u2019s disease: a possible role for Bcl-2. J Pathol 201:504\u2013512","journal-title":"J Pathol"},{"key":"188_CR30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1172\/JCI2004","volume":"102","author":"TA Hentunen","year":"1998","unstructured":"Hentunen TA, Reddy SV, Boyce BF et\u00a0al (1998) Immortalization of osteoclast precursors by targeting Bcl-XL and Simian virus 40 large T antigen to the osteoclast lineage in transgenic mice. J Clin Invest 102:88\u201397","journal-title":"J Clin Invest"},{"key":"188_CR31","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1002\/art.21236","volume":"52","author":"Q Zhang","year":"2005","unstructured":"Zhang Q, Badell IR, Schwarz EM et\u00a0al (2005) Tumor necrosis factor prevents alendronate-induced osteoclast apoptosis in\u00a0vivo by stimulating Bcl-xL expression through Ets-2. Arthritis Rheum 52:2708\u20132718","journal-title":"Arthritis Rheum"},{"key":"188_CR32","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1021\/bi001603q","volume":"40","author":"S Shin","year":"2001","unstructured":"Shin S, Sung BJ, Cho YS et\u00a0al (2001) An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry 40:1117\u20131123","journal-title":"Biochemistry"},{"key":"188_CR33","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1182\/blood-2007-04-084996","volume":"110","author":"KS Ahn","year":"2007","unstructured":"Ahn KS, Sethi G, Chao TH et\u00a0al (2007) Salinosporamide A (NPI-0052) potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through down-modulation of NF-kappaB regulated gene products. Blood 110:2286\u20132295","journal-title":"Blood"},{"key":"188_CR34","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1023\/B:APPT.0000045780.10463.c6","volume":"9","author":"AC Bharti","year":"2004","unstructured":"Bharti AC, Aggarwal BB (2004) Ranking the role of RANK ligand in apoptosis. Apoptosis 9:677\u2013690","journal-title":"Apoptosis"},{"key":"188_CR35","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/jcb.21331","volume":"102","author":"MJ Hodge","year":"2007","unstructured":"Hodge MJ, Kirkland MA, Nicholson G (2007) Multiple roles of M-CSF in human osteoclastogenesis. J Cell Biochem 102:759\u2013768","journal-title":"J Cell Biochem"},{"key":"188_CR36","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/jcb.240550311","volume":"55","author":"R Felix","year":"1994","unstructured":"Felix R, Hofstetter W, Wetterwald A, Cecchini MG, Fleisch H (1994) Role of colony-stimulating factor-1 in bone metabolism. J Cel Bioch 55:340\u2013349","journal-title":"J Cel Bioch"},{"key":"188_CR37","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1074\/jbc.M308062200","volume":"279","author":"AC Bharti","year":"2004","unstructured":"Bharti AC, Takada Y, Shishodia S, Aggarwal BB (2004) Evidence that receptor activator of nuclear factor (NF)-kappaB ligand can suppress cell proliferation and induce apoptosis through activation of a NF-kappaB independent and TRAF6-dependent mechanism. J Biol Chem 279:6065\u20136076","journal-title":"J Biol Chem"},{"key":"188_CR38","doi-asserted-by":"crossref","unstructured":"Del Fattore A, Teti A, Rucci N (2008) Osteoclast receptors and signaling. Arch Biochem Biophys. doi: 10.1016\/j.abb.2008.01.011 (In press)","DOI":"10.1016\/j.abb.2008.01.011"},{"key":"188_CR39","doi-asserted-by":"crossref","first-page":"7308","DOI":"10.1158\/0008-5472.CAN-06-4130","volume":"67","author":"F Lamoureux","year":"2007","unstructured":"Lamoureux F, Richard P, Wittrant Y et\u00a0al (2007) Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma: blockade of the vicious cycle between tumor cell proliferation and bone resorption. Cancer Res 67:7308\u20137318","journal-title":"Cancer Res"},{"key":"188_CR40","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/sj.cdd.4401946","volume":"14","author":"K Hettinger","year":"2007","unstructured":"Hettinger K, Vikhanskaya F, Poh MK et\u00a0al (2007) c-Jun promotes cellular survival by suppression of PTEN. Cell Death Differ 14:218\u2013229","journal-title":"Cell Death Differ"},{"key":"188_CR41","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/sj.cdd.4401285","volume":"10","author":"H Glantschnig","year":"2003","unstructured":"Glantschnig H, Fisher JE, Wesolowski G, Rodan GA, Reszka AA (2003) M-CSF, TNFa and RANK ligand promote osteoclast survival by signaling through mTOR\/S6 kinase. Cell Death Differ 10:1165\u20131177","journal-title":"Cell Death Differ"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-008-0188-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10495-008-0188-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-008-0188-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T14:41:04Z","timestamp":1559140864000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10495-008-0188-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,29]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["188"],"URL":"https:\/\/doi.org\/10.1007\/s10495-008-0188-7","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,29]]}}}